Marco Roffi

Showing 1-20 of 21 articles

Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

Chieffo A, Tarantini G, Naber C, Barbato E, Roffi M, Stefanini G, Buchanan G, Buszman P, Moreno R, Zawiślak B, Cayla G, Danenberg H, Da Silveira J, Nef H, James S, Mauri Ferre J, Voskuil M, Witt N, Windecker S, Baumbach A, Dudek D

February 19, 2021 | 10.4244/EIJ-D-20-01291

Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

January 8, 2021 | 10.4244/EIJ-D-20-01291

Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registry

Mohamed M, Polad J, Hildick-Smith D, Bizeau O, Baisebenov R, Roffi M, Iniguez-Romo A, Chevalier B, von Birgelen C, Roguin A, Aminian A, Angioi M, Mamas M

September 18, 2020 | 10.4244/EIJ-D-20-00361

Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registry

Mohamed M, Polad J, Hildick-Smith D, Bizeau O, Baisebenov R, Roffi M, Iniguez-Romo A, Chevalier B, von Birgelen C, Roguin A, Aminian A, Angioi M, Mamas M

June 25, 2020 | 10.4244/EIJ-D-20-00361

EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic

Chieffo A, Stefanini G, Price S, Barbato E, Tarantini G, Karam N, Moreno R, Buchanan G, Gilard M, Halvorsen S, Huber K, James S, Neumann F, Möllmann H, Roffi M, Tavazzi G, Mauri Ferre J, Windecker S, Dudek D, Baumbach A

June 25, 2020 | 10.4244/EIJY20M05_01

Impact of the COVID-19 pandemic on interventional cardiology practice: results of the EAPCI survey

Roffi M, Capodanno D, Windecker S, Baumbach A, Dudek D

June 25, 2020 | 10.4244/EIJ-D-20-00528

Patient focus in interventional cardiology: proceedings of the 2018 summit of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) – Nice, France, 20-21 June 2018

Barbato E, Mauri Ferre J, Byrne R, Roffi M, Fitzsimons D, Toth G, Capodanno D, Mehilli J, Petronio A, Chieffo A, Vardas P, Naber C, Dudek D, Haude M, Baumbach A

April 16, 2019 | 10.4244/EIJV14I17A297

A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial

Iglesias JF, Mueller O, Zaugg S, Roffi M, Kurz D, Vuilliomenet A, Weilenmann D, Kaiser C, Tapponnier M, Heg D, Valgimigli M, Eeckhout E, Jüni P, Windecker S, Pilgrim T

August 24, 2018 | 10.4244/EIJ-D-17-00734

Coronary interventions

Switzerland: coronary and structural heart interventions from 2010 to 2015

Rigamonti F, Fahrni G, Maeder M, Cook S, Weilenmann D, Wenaweser P, Rothlisberger C, Corti R, Rickli H, Kaiser C, Roffi M

May 15, 2017 | 10.4244/EIJ-D-16-00828

Coronary interventions

First-in-man six-month results of a surface-modified coronary stent system in native coronary stenosis

Suwannasom P, Sotomi Y, Corti R, Kurz D, Roffi M, von Birgelen C, Buzzi S, Zucker A, Dijkstra J, Wykrzykowska J, de Winter R, Windecker S, Onuma Y, Serruys P, Daemen J, Räber L

April 20, 2017 | 10.4244/EIJ-D-16-00975

Interventions for valvular disease

Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis

Noble S, Stortecky S, Heg D, Tueller D, Jeger R, Toggweiler S, Ferrari E, Nietlispach F, Taramasso M, Maisano F, Grünenfelder J, Jüni P, Huber C, Carrel T, Windecker S, Wenaweser P, Roffi M

April 7, 2017 | 10.4244/EIJ-D-16-00677

Coronary interventions

Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction

Pilgrim T, Piccolo R, Heg D, Roffi M, Tüller D, Vuilliomenet A, Mueller O, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Khattab A, Taniwaki M, Rigamonti F, Nietlispach F, Blochlinger S, Wenaweser P, Jüni P, Windecker S

December 9, 2016 | 10.4244/EIJY15M12_09

Coronary interventions

Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trial

Franzone A, Taniwaki M, Rigamonti F, Heg D, Piccolo R, Roffi M, Tüller D, Mueller O, Vuilliomenet A, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Jüni P, Windecker S, Pilgrim T

August 5, 2016 | 10.4244/EIJV12I5A99

Interventions for heart failure

Long-term prognosis after extracorporeal life support in refractory cardiogenic shock: results from a real-world cohort

Rigamonti F, Banfi C, Roffi M, Giraud R

June 20, 2016 | 10.4244/EIJV12I3A70

Guidewires for lower extremity artery angioplasty: a review

Lorenzoni R, Ferraresi R, Manzi M, Roffi M

November 20, 2015 | 10.4244/EIJV11I7A164

Short-term clinical outcomes among patients undergoing transcatheter aortic valve implantation in Switzerland: the Swiss TAVI registry

Wenaweser P, Stortecky S, Heg D, Tueller D, Nietlispach F, Falk V, Pedrazzini G, Jeger R, Reuthebuch O, Carrel T, Räber L, Amann F, Ferrari E, Toggweiler S, Noble S, Roffi M, Gruenenfelder J, Jüni P, Windecker S, Huber C

December 22, 2014 | 10.4244/EIJV10I8A166

AngioJet rheolytic thrombectomy in patients presenting with high-risk pulmonary embolism and cardiogenic shock: a feasibility pilot study

Bonvini R, Roffi M, Bounameaux H, Noble S, Müller H, Keller P, Jolliet P, Sarasin F, Rutschmann O, Bendjelid K, Righini M

April 19, 2013 | 10.4244/EIJV8I12A215

Comparison of biolimus eluted from an erodible stent coating with bare metal stents in acute ST-elevation myocardial infarction (COMFORTABLE AMI trial): rationale and design

Räber L, Kelbæk H, Ostojic M, Baumbach A, Tüller D, von Birgelen C, Roffi M, Pedrazzini G, Kornowski R, Weber K, Heg D, Matter C, Lüscher T, Taniwaki M, Meier B, Jüni P, Windecker S

April 20, 2012 | 10.4244/EIJV7I12A224

Peripheral interventions: how long will they remain a missed opportunity?

Di Mario C, Roffi M

June 30, 2011 | 10.4244/EIJV7I2A30

Fatal coronary sinus and aortic erosions following percutaneous transvenous mitral annuloplasty device

Noble S, Vilarino R, Müller H, Sunthorn H, Roffi M

May 17, 2011 | 10.4244/EIJV7I1A24

Latest news

NEW ISSUE

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

News

Don’t Miss #EIJOnAir 2nd Edition!

Elective cardiac invasive procedures during the COVID-19 outbreak

March 4, 2021

Ahead of Print

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

March 2, 2021

Editorial

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

March 2, 2021

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

JAA

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

March 2, 2021

Guidance Papers

Guidelines, consensus & position papers